Aug 25 (Reuters) - Genetic Signatures Ltd (GSS) :
- INFLUENZA B DETECTION EXPECTED TO IMPACT ON QUARTER SALES
- A UNDERTAKEN AN INVESTIGATION
- WELL-ADVANCED IN RESOLVING THE ISSUE, WHICH IS SPECIFIC TO INFLUENZA B VIRUS
- FOUND SEASON'S INFLUENZA B VIRUS IS NOT BEING CONSISTENTLY DETECTED IN A SMALL PROPORTION OF LOW VIRAL CONCENTRATION SAMPLES
- AT THIS TIME, WE EXPECT FORECAST REVENUE TO BE ABOUT A$2 MILLION FOR Q1 FY2023
- DETECTION OF INFLUENZA A VIRUS IS UNAFFECTED.
- IN INTERIM, SALE OF GENETIC SIGNATURES EASYSCREEN™ RESPIRATORY PATHOGEN DETECTION KIT HAS BEEN IMPACTED DURING THIS CURRENT QUARTER
- Forums
- ASX - By Stock
- GSS
- News: GSS Genetic Signatures Says Influenza B Detection Expected To Impact On Quarter Sales
GSS
genetic signatures limited
Add to My Watchlist
2.67%
!
36.5¢

News: GSS Genetic Signatures Says Influenza B Detection Expected To Impact On Quarter Sales
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $82.90M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.5¢ | $160 | 438 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19601 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 32411 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14601 | 0.365 |
2 | 9513 | 0.360 |
3 | 30509 | 0.350 |
1 | 1683 | 0.300 |
1 | 25000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 32411 | 1 |
0.380 | 3086 | 1 |
0.390 | 20000 | 1 |
0.395 | 5000 | 1 |
0.400 | 111918 | 2 |
Last trade - 13.38pm 04/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online